Vericel (VCEL) EBT Margin (2011 - 2026)
Vericel recorded quarterly EBT Margin of 9.31% in Q1 2026, down 135.85% quarter-over-quarter from 25.98% in Q4 2025, and up 1215.0% year-over-year from 0.71% in Q1 2025.
Vericel's EBT Margin history runs 16 years deep, the most recent figure standing at 9.31% for Q1 2026.
- In Q1 2026, EBT Margin rose 1215.0% year-over-year to 9.31%; the TTM figure through Mar 2026 stood at 7.65% (up 635.0% YoY), while the FY2025 annual figure was 6.29%, up 186.0% from the prior year.
- EBT Margin came in at 9.31% for Q1 2026 at Vericel, down from 25.98% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 26.47% in Q4 2024 to a low of 24.19% in Q2 2022.
- A 5-year average of 3.18% and a median of 8.66% in 2023 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin sank 1480 bps in 2022 and soared 1327 bps in 2023, its largest moves.
- Vericel's EBT Margin stood at 12.57% in 2022, then soared by 73 bps to 21.68% in 2023, then gained by 22 bps to 26.47% in 2024, then dropped by 2 bps to 25.98% in 2025, then slumped by 136 bps to 9.31% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 9.31%, 25.98%, and 7.56% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | -9.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.31% |
| Dec 31, 2025 | 25.98% |
| Sep 30, 2025 | 7.56% |
| Jun 30, 2025 | -0.84% |
| Mar 31, 2025 | -21.46% |
| Dec 31, 2024 | 26.47% |
| Sep 30, 2024 | -1.56% |
| Jun 30, 2024 | -8.88% |
| Mar 31, 2024 | -7.52% |
| Dec 31, 2023 | 21.68% |
| Sep 30, 2023 | -8.66% |
| Jun 30, 2023 | -10.92% |
| Mar 31, 2023 | -18.24% |
| Dec 31, 2022 | 12.57% |
| Sep 30, 2022 | -17.01% |
| Jun 30, 2022 | -24.19% |
| Mar 31, 2022 | -19.78% |
| Dec 31, 2021 | 8.84% |
| Sep 30, 2021 | -14.29% |
| Jun 30, 2021 | -9.40% |
| Mar 31, 2021 | -9.36% |
| Dec 31, 2020 | 27.42% |
| Sep 30, 2020 | 11.22% |
| Jun 30, 2020 | -41.32% |
| Mar 31, 2020 | -17.64% |
| Dec 31, 2019 | 24.19% |
| Sep 30, 2019 | 11.41% |
| Jun 30, 2019 | -75.61% |
| Mar 31, 2019 | -13.20% |
| Dec 31, 2018 | 24.93% |
| Sep 30, 2018 | -6.62% |
| Jun 30, 2018 | -24.25% |
| Mar 31, 2018 | -26.37% |
| Dec 31, 2017 | 8.50% |
| Sep 30, 2017 | -30.48% |
| Jun 30, 2017 | -16.62% |
| Mar 31, 2017 | -105.59% |
| Dec 31, 2016 | 5.43% |
| Sep 30, 2016 | -59.16% |
| Jun 30, 2016 | -38.88% |
| Mar 31, 2016 | -14.11% |
| Dec 31, 2015 | -32.12% |
| Sep 30, 2015 | -43.08% |
| Jun 30, 2015 | -16.62% |
| Mar 31, 2015 | -42.04% |
| Dec 31, 2014 | -15.86% |
| Sep 30, 2014 | -83.04% |
| Jun 30, 2014 | -192.24% |
| Dec 31, 2013 | -61,525.00% |
| Jun 30, 2013 | -174,466.67% |
| Mar 31, 2013 | -89,537.50% |
| Dec 31, 2012 | -40,047.37% |
| Mar 31, 2012 | -427,750.00% |
| Sep 30, 2011 | -82,555.56% |
| Mar 31, 2011 | -69,355.56% |